Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. | J Transl Med | 2023 | 37784157 | PubTator, text mining | PubMed |
| Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment. | Vaccines (Basel) | 2023 | 37766141 | PubTator, text mining | PubMed |
| Photothermal Effect of Gold Nanoparticles as a Nanomedicine for Diagnosis and Therapeutics. | Pharmaceutics | 2023 | 37765317 | PubTator, text mining | PubMed |
| A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. | Biomedicines | 2023 | 37760930 | PubTator, text mining | PubMed |
| Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model. | Cancer Cell Int | 2023 | 37759302 | PubTator, text mining | PubMed |
| Modulation of lytic molecules restrain serial killing in γδ T lymphocytes. | Nat Commun | 2023 | 37758698 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| Application of cell-derived exosomes in the hematological malignancies therapy. | Front Pharmacol | 2023 | 37745073 | PubTator, text mining | PubMed |
| The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. | Cell Commun Signal | 2023 | 37735675 | PubTator, text mining | PubMed |
| The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer. | Cancer Biol Med | 2023 | 37731205 | PubTator, text mining | PubMed |
| Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease. | Science | 2023 | 37708268 | PubTator, text mining | PubMed |
| The influence of anti-cancer therapies on lymphocyte subpopulations of lung cancer patients. | Front Immunol | 2023 | 37701442 | PubTator, text mining | PubMed |
| Update on immune-based therapy strategies targeting cancer stem cells. | Cancer Med | 2023 | 37698048 | PubTator, text mining | PubMed |
| Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation. | Exp Mol Med | 2023 | 37696896 | PubTator, text mining | PubMed |
| mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. | Cancers (Basel) | 2023 | 37686697 | PubTator, text mining | PubMed |
| Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD2-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2. | Cancers (Basel) | 2023 | 37686586 | PubTator, text mining | PubMed |
| Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells. | Int J Mol Sci | 2023 | 37686362 | PubTator, text mining | PubMed |
| Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential. | Front Immunol | 2023 | 37675125 | PubTator, text mining | PubMed |
| Innate adaptive immune cell dynamics in tonsillar tissues during chronic SIV infection. | Front Immunol | 2023 | 37671159 | PubTator, text mining | PubMed |
| Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism. | PLoS Pathog | 2023 | 37669308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=11